POLL RESULTS AT THE ANNUAL GENERAL MEETING OF KONTAFARMA CHINA HOLDINGS LIMITED
Kontafarma China Holdings Limited (the Company) has released the results of its Annual General Meeting (AGM) held on 5 June 2026. The meeting was marked by a decisive show of support for all proposed resolutions, with shareholders voting overwhelmingly in favour. Below is a detailed breakdown of the key outcomes and salient points for investors.
Key Highlights from the AGM
- Resolutions Passed: All ordinary and special resolutions were passed, with over 95% of shares voted in favour.
- Strong Shareholder Support: 3,172,787,450 shares (95.85%) were voted for each resolution, while only 137,500,000 shares (4.15%) were voted against.
- Director Re-elections: The re-election of key executive and non-executive directors, including Mr. Wang Limin (Chairman and President), Mr. Ge Shouwen (Vice President), Ms. Guo Zixiu (Financial Controller), Mr. Huang Yu (non-executive Director), and Dr. Ho Ho Ming (independent non-executive Director), was approved.
- Director Fees: Board was authorised to fix directors’ fees for the year ending 31 December 2026.
- Auditor Appointment: BDO Limited was re-appointed as independent auditor, with the Board authorised to fix their remuneration.
- General Mandates: Shareholders granted the Board general mandates to issue securities (including treasury shares), buy back shares, and extend the issue mandate.
- Special Resolution: Proposed amendments to the memorandum and articles of association and adoption of new articles were approved, with more than 75% of votes in favour.
Important Information for Shareholders
- Voting Rights: As of the AGM date, there were 5,588,571,777 issued shares entitled to vote. No shares were required to abstain from voting or entitled to attend and abstain in favour, as per Hong Kong listing rules.
- No Treasury Shares: The Company had no treasury shares or repurchased shares pending cancellation, ensuring full transparency in voting.
- Board Attendance: All directors attended the AGM except Mr. Huang Yu.
- Vote Scrutiny: Tricor Investor Services Limited acted as scrutineer for vote-taking.
Potentially Price-Sensitive Developments
- Corporate Governance Stability: The re-election of the entire executive management team and approval of new articles reinforce confidence in the Company’s governance and strategic direction. This stability may be viewed positively by investors, potentially impacting share value.
- General Mandates: The approval of broad mandates for the Board to issue securities and buy back shares provides flexibility for future capital raising or share repurchase activities, which can have direct effects on share liquidity and price.
- Memorandum & Articles Amendments: The adoption of a new memorandum and articles of association can signal changes to corporate structure, governance, or operational flexibility, which could be material to shareholders and affect the Company’s valuation.
Other Noteworthy Details
- Resolutions Passed: All resolutions were passed with overwhelming majority; no shareholder indicated intention to vote against or abstain from any resolution.
- Board Composition: The Board now comprises three executive directors (Mr. Wang Limin, Mr. Ge Shouwen, Ms. Guo Zixiu), one non-executive director (Mr. Huang Yu), and three independent non-executive directors (Dr. Tang Lai Wah, Dr. Ho Ho Ming, Mr. Yao Xiaomin).
Investor Takeaways
Investors should note the strong shareholder support for the current management and corporate structure, as well as the enhanced flexibility granted to the Board for future corporate actions. These developments may affect the Company’s share price, especially in the context of potential security issuances or buybacks and changes to the articles of association.
Disclaimer: This article is intended for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions.
康達華中國控股有限公司股東周年大會投票結果詳情
康達華中國控股有限公司（下稱「公司」）已公布其於2026年6月5日舉行之股東周年大會（AGM）投票結果。會議上所有提案均獲得股東壓倒性支持，以下為投票結果及投資者需注意的重點詳情。
股東大會關鍵重點
- 議案通過：所有普通及特別決議案均獲超過95%股份支持。
- 股東支持強勁：每項議案均有3,172,787,450股（95.85%）贊成，僅137,500,000股（4.15%）反對。
- 董事重選：包括王立民（主席及總裁）、葛壽文（副總裁）、郭子秀（財務總監）、黃宇（非執行董事）及何浩明（獨立非執行董事）等董事重選均獲通過。
- 董事酬金：董事會獲授權決定2026年度董事酬金。
- 審計師任命：BDO Limited再次獲任為獨立審計師，董事會獲授權決定其酬金。
- 一般授權：股東授權董事會發行證券（包括庫藏股）、回購股份及延長發行授權。
- 特別決議：修訂及採納新公司章程獲超過75%投票支持。
股東需注意事項
- 投票權：會議當日共有5,588,571,777發行股份具投票權，無需避席或特別投票安排。
- 無庫藏股：公司並無庫藏股或待註銷股份，投票完全透明。
- 董事出席：除黃宇外，所有董事均出席大會。
- 票數監察：Tricor Investor Services Limited擔任投票監察員。
可能影響股價的重要事項
- 公司治理穩定：全體管理層重選及新章程獲通過，增強市場對公司治理及策略方向信心，有機會正面影響股價。
- 一般授權：董事會獲授權發行及回購股份，提升未來資金運作及股份流動性，直接影響股價。
- 章程修訂：新章程或涉及公司架構、治理或運作彈性變動，屬股東重大事項，可能對股價產生影響。
其他重要細節
- 議案通過：所有議案均以絕大多數通過，無股東表示反對或避席。
- 董事構成：現董事會由三名執行董事（王立民、葛壽文、郭子秀）、一名非執行董事（黃宇）及三名獨立非執行董事（鄧麗華、何浩明、姚曉民）組成。
投資者提示
投資者應注意現任管理層及公司架構獲得強大支持，董事會亦獲更大彈性進行未來資本運作。以上發展或影響公司股價，特別是發行新證券、股份回購及章程修訂。
免責聲明：本文僅供資訊參考，不構成任何投資建議。投資者應自行進行盡職調查，並諮詢專業顧問後再作投資決定。
